ILD medications: immunosuppressive drugs

ILD_IMMUNOSUPPRESSIVE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L04A

23932

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

21017

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

21017

diagram downward connector

Include endpoints None

21017

diagram downward connector
ILD_IMMUNOSUPPRESSIVE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 21017 12829 8188
Unadjusted prevalence (%) 5.91 6.47 5.20
Mean age at first event (years) 49.93 48.87 51.58

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 2.89 [2.36, 3.53] 4.1e-25 1389
15 years 0.01 1.89 [1.56, 2.28] 9.3e-11 704
5 years 0.00 3.70 [3.12, 4.37] 3.2e-52 428
1 year 0.00 4.38 [3.41, 5.62] 3.7e-31 92

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: ILD_IMMUNOSUPPRESSIVE – ILD medications: immunosuppressive drugs
GWS hits:

Survival analyses between endpoints

Plot

before ILD medications: immunosuppressive drugs
after ILD medications: immunosuppressive drugs

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD medications: immunosuppressive drugs